159 related articles for article (PubMed ID: 27793474)
1. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.
Natelson Love M; Clark DG; Cochran JN; Den Beste KA; Geldmacher DS; Benzinger TL; Gordon BA; Morris JC; Bateman RJ; Roberson ED
Neurobiol Aging; 2017 Jan; 49():216.e7-216.e13. PubMed ID: 27793474
[TBL] [Abstract][Full Text] [Related]
2. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
[TBL] [Abstract][Full Text] [Related]
3. Presenilin-1 mutation is associated with a hippocampus defect in alzheimer's disease: Meta-Analysis for neuroimaging research.
Gu X; Zhao M; Han X; Liu L
Clin Neurol Neurosurg; 2020 Apr; 191():105679. PubMed ID: 32004985
[TBL] [Abstract][Full Text] [Related]
4. A novel V272D presenilin mutation associated with logopenia, disorientation, and apraxia in an autosomal-dominant Alzheimer's disease family.
Mengel D; Liu L; Yamamoto R; Zülow S; Deuschl C; Hermann DM; Zerr I; Selkoe DJ; Dodel R
Neurobiol Aging; 2020 Jan; 85():154.e5-154.e7. PubMed ID: 31500908
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease.
Vo VG; Pyun JM; Bagyinszky E; An SSA; Kim SY
Curr Alzheimer Res; 2020; 17(5):438-445. PubMed ID: 32589559
[TBL] [Abstract][Full Text] [Related]
6. The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
Gallo M; Frangipane F; Cupidi C; De Bartolo M; Turone S; Ferrari C; Nacmias B; Grimaldi G; Laganà V; Colao R; Bernardi L; Anfossi M; Conidi ME; Vasso F; Curcio SAM; Mirabelli M; Smirne N; Torchia G; Muraca MG; Puccio G; Di Lorenzo R; Piccininni M; Tedde A; Maletta RG; Sorbi S; Bruni AC
Neurobiol Aging; 2017 Aug; 56():213.e7-213.e12. PubMed ID: 28532646
[TBL] [Abstract][Full Text] [Related]
7. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.
Ringman JM; Gylys KH; Medina LD; Fox M; Kepe V; Flores DL; Apostolova LG; Barrio JR; Small G; Silverman DH; Siu E; Cederbaum S; Hecimovic S; Malnar M; Chakraverty S; Goate AM; Bird TD; Leverenz JB
Neurosci Lett; 2011 Jan; 487(3):287-92. PubMed ID: 21094210
[TBL] [Abstract][Full Text] [Related]
8. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
Thordardottir S; Rodriguez-Vieitez E; Almkvist O; Ferreira D; Saint-Aubert L; Kinhult-Ståhlbom A; Thonberg H; Schöll M; Westman E; Wall A; Eriksdotter M; Zetterberg H; Blennow K; Nordberg A; Graff C
Alzheimers Res Ther; 2018 May; 10(1):45. PubMed ID: 29747683
[TBL] [Abstract][Full Text] [Related]
9. A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF.
Uttner I; Kirchheiner J; Tumani H; Mottaghy FM; Lebedeva E; Ozer E; Ludolph AC; Huber R; von Arnim CA
Eur J Neurol; 2010 Apr; 17(4):631-3. PubMed ID: 19912322
[TBL] [Abstract][Full Text] [Related]
10. A novel pathogenic PSEN1 mutation in a family with Alzheimer's disease: phenotypical and neuropathological features.
Gallo M; Marcello N; Curcio SA; Colao R; Geracitano S; Bernardi L; Anfossi M; Puccio G; Frangipane F; Clodomiro A; Mirabelli M; Vasso F; Smirne N; Muraca G; Di Lorenzo R; Maletta R; Ghidoni E; Bugiani O; Tagliavini F; Giaccone G; Bruni AC
J Alzheimers Dis; 2011; 25(3):425-31. PubMed ID: 21422519
[TBL] [Abstract][Full Text] [Related]
11. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
Knight WD; Okello AA; Ryan NS; Turkheimer FE; Rodríguez Martinez de Llano S; Edison P; Douglas J; Fox NC; Brooks DJ; Rossor MN
Brain; 2011 Jan; 134(Pt 1):293-300. PubMed ID: 21084313
[TBL] [Abstract][Full Text] [Related]
12. A novel presenilin 1 mutation (V261L) associated with presenile Alzheimer's disease and spastic paraparesis.
Jiménez Caballero PE; Lladó A; de Diego Boguna C; Martin Correa E; Serviá Candela M; Marsal Alonso C
Eur J Neurol; 2008 Sep; 15(9):991-4. PubMed ID: 18637955
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel PSEN1 Gly111Val missense mutation in a Chinese pedigree with early-onset Alzheimer's disease.
Qiu Q; Jia L; Wang Q; Zhao L; Jin H; Li T; Quan M; Xu L; Li B; Li Y; Jia J
Neurobiol Aging; 2020 Jan; 85():155.e1-155.e4. PubMed ID: 31235344
[TBL] [Abstract][Full Text] [Related]
14. Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.
Fuller JT; Cronin-Golomb A; Gatchel JR; Norton DJ; Guzmán-Vélez E; Jacobs HIL; Hanseeuw B; Pardilla-Delgado E; Artola A; Baena A; Bocanegra Y; Kosik KS; Chen K; Tariot PN; Johnson K; Sperling RA; Reiman EM; Lopera F; Quiroz YT
J Prev Alzheimers Dis; 2019; 6(2):112-120. PubMed ID: 30756118
[TBL] [Abstract][Full Text] [Related]
15. Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization.
Shen L; Qin W; Wu L; Zhou A; Tang Y; Wang Q; Jia L; Jia J
Biochem Biophys Res Commun; 2019 Aug; 516(1):264-269. PubMed ID: 31235249
[TBL] [Abstract][Full Text] [Related]
16. Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer's Disease.
Ma L; Wang F; Chen S; Wang S; Wang Z; Xia M; Li Y; Ma H; Shang J; Zhang J
Neuromolecular Med; 2024 Mar; 26(1):6. PubMed ID: 38504005
[TBL] [Abstract][Full Text] [Related]
17. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
[TBL] [Abstract][Full Text] [Related]
18. The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer's disease family.
Li H; Li Y; Liang W; Wei ZZ; Li X; Tian Y; Qiao S; Yang Y; Yang L; Wu D; Yin W; Liu H; Zhang W; Zhang Y; Wang Z
Mol Cell Neurosci; 2022 May; 120():103715. PubMed ID: 35247599
[TBL] [Abstract][Full Text] [Related]
19. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.
Dermaut B; Kumar-Singh S; De Jonghe C; Cruts M; Löfgren A; Lübke U; Cras P; Dom R; De Deyn PP; Martin JJ; Van Broeckhoven C
Brain; 2001 Dec; 124(Pt 12):2383-92. PubMed ID: 11701593
[TBL] [Abstract][Full Text] [Related]
20. A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman.
Ting SK; Benzinger T; Kepe V; Fagan A; Coppola G; Porter V; Hecimovic S; Chakraverty S; Alvarez-Retuerto AI; Goate A; Ringman JM
J Alzheimers Dis; 2014; 40(2):271-5. PubMed ID: 24413619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
